nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP1A2—Dacarbazine—pancreatic cancer	0.0484	0.121	CbGbCtD
Bromocriptine—CYP1A2—Tamoxifen—pancreatic cancer	0.0385	0.096	CbGbCtD
Bromocriptine—ABCB1—Tamoxifen—pancreatic cancer	0.0337	0.0839	CbGbCtD
Bromocriptine—CYP1A2—Erlotinib—pancreatic cancer	0.0327	0.0816	CbGbCtD
Bromocriptine—ABCB1—Gemcitabine—pancreatic cancer	0.029	0.0723	CbGbCtD
Bromocriptine—ABCB1—Erlotinib—pancreatic cancer	0.0286	0.0714	CbGbCtD
Bromocriptine—CYP1A2—Fluorouracil—pancreatic cancer	0.0284	0.0707	CbGbCtD
Bromocriptine—ABCB1—Irinotecan—pancreatic cancer	0.0258	0.0645	CbGbCtD
Bromocriptine—CYP3A4—Tamoxifen—pancreatic cancer	0.0202	0.0503	CbGbCtD
Bromocriptine—ABCB1—Docetaxel—pancreatic cancer	0.0189	0.0472	CbGbCtD
Bromocriptine—ABCB1—Sunitinib—pancreatic cancer	0.0189	0.047	CbGbCtD
Bromocriptine—CYP3A4—Erlotinib—pancreatic cancer	0.0171	0.0428	CbGbCtD
Bromocriptine—CYP3A4—Irinotecan—pancreatic cancer	0.0155	0.0386	CbGbCtD
Bromocriptine—ABCB1—Doxorubicin—pancreatic cancer	0.0141	0.0352	CbGbCtD
Bromocriptine—CYP3A4—Docetaxel—pancreatic cancer	0.0113	0.0283	CbGbCtD
Bromocriptine—CYP3A4—Sunitinib—pancreatic cancer	0.0113	0.0282	CbGbCtD
Bromocriptine—CYP3A4—Doxorubicin—pancreatic cancer	0.00846	0.0211	CbGbCtD
Bromocriptine—HTR7—enteric nervous system—pancreatic cancer	0.00148	0.469	CbGeAlD
Bromocriptine—HTR2A—enteric nervous system—pancreatic cancer	0.000921	0.292	CbGeAlD
Bromocriptine—Dermatitis—Tamoxifen—pancreatic cancer	0.000396	0.00131	CcSEcCtD
Bromocriptine—Ataxia—Epirubicin—pancreatic cancer	0.000396	0.00131	CcSEcCtD
Bromocriptine—Vomiting—Erlotinib—pancreatic cancer	0.000396	0.00131	CcSEcCtD
Bromocriptine—Dyspnoea—Irinotecan—pancreatic cancer	0.000396	0.00131	CcSEcCtD
Bromocriptine—Somnolence—Irinotecan—pancreatic cancer	0.000394	0.00131	CcSEcCtD
Bromocriptine—Headache—Tamoxifen—pancreatic cancer	0.000394	0.0013	CcSEcCtD
Bromocriptine—Rash—Erlotinib—pancreatic cancer	0.000392	0.0013	CcSEcCtD
Bromocriptine—Dermatitis—Erlotinib—pancreatic cancer	0.000392	0.0013	CcSEcCtD
Bromocriptine—Angiopathy—Docetaxel—pancreatic cancer	0.000392	0.0013	CcSEcCtD
Bromocriptine—Insomnia—Gemcitabine—pancreatic cancer	0.000391	0.00129	CcSEcCtD
Bromocriptine—Dyspepsia—Irinotecan—pancreatic cancer	0.000391	0.00129	CcSEcCtD
Bromocriptine—Headache—Erlotinib—pancreatic cancer	0.00039	0.00129	CcSEcCtD
Bromocriptine—Diplopia—Doxorubicin—pancreatic cancer	0.000389	0.00129	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000389	0.00129	CcSEcCtD
Bromocriptine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000389	0.00129	CcSEcCtD
Bromocriptine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000388	0.00128	CcSEcCtD
Bromocriptine—Asthenia—Sunitinib—pancreatic cancer	0.000386	0.00128	CcSEcCtD
Bromocriptine—Decreased appetite—Irinotecan—pancreatic cancer	0.000386	0.00128	CcSEcCtD
Bromocriptine—Arrhythmia—Docetaxel—pancreatic cancer	0.000386	0.00128	CcSEcCtD
Bromocriptine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000385	0.00128	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000384	0.00127	CcSEcCtD
Bromocriptine—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000384	0.00127	CcSEcCtD
Bromocriptine—Insomnia—Fluorouracil—pancreatic cancer	0.000384	0.00127	CcSEcCtD
Bromocriptine—Somnolence—Gemcitabine—pancreatic cancer	0.000384	0.00127	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000383	0.00127	CcSEcCtD
Bromocriptine—Fatigue—Irinotecan—pancreatic cancer	0.000383	0.00127	CcSEcCtD
Bromocriptine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000382	0.00126	CcSEcCtD
Bromocriptine—Alopecia—Docetaxel—pancreatic cancer	0.000381	0.00126	CcSEcCtD
Bromocriptine—Constipation—Irinotecan—pancreatic cancer	0.000379	0.00126	CcSEcCtD
Bromocriptine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000379	0.00125	CcSEcCtD
Bromocriptine—Mental disorder—Docetaxel—pancreatic cancer	0.000378	0.00125	CcSEcCtD
Bromocriptine—Somnolence—Fluorouracil—pancreatic cancer	0.000378	0.00125	CcSEcCtD
Bromocriptine—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000376	0.00125	CcSEcCtD
Bromocriptine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000376	0.00124	CcSEcCtD
Bromocriptine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000374	0.00124	CcSEcCtD
Bromocriptine—Nausea—Tamoxifen—pancreatic cancer	0.000374	0.00124	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000373	0.00124	CcSEcCtD
Bromocriptine—Fatigue—Gemcitabine—pancreatic cancer	0.000373	0.00123	CcSEcCtD
Bromocriptine—Constipation—Gemcitabine—pancreatic cancer	0.00037	0.00122	CcSEcCtD
Bromocriptine—Nausea—Erlotinib—pancreatic cancer	0.00037	0.00122	CcSEcCtD
Bromocriptine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000369	0.00122	CcSEcCtD
Bromocriptine—Diarrhoea—Sunitinib—pancreatic cancer	0.000369	0.00122	CcSEcCtD
Bromocriptine—Dysgeusia—Docetaxel—pancreatic cancer	0.000368	0.00122	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000367	0.00121	CcSEcCtD
Bromocriptine—Ataxia—Doxorubicin—pancreatic cancer	0.000366	0.00121	CcSEcCtD
Bromocriptine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000366	0.00121	CcSEcCtD
Bromocriptine—Influenza—Epirubicin—pancreatic cancer	0.000364	0.0012	CcSEcCtD
Bromocriptine—Dysphagia—Epirubicin—pancreatic cancer	0.000364	0.0012	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000363	0.0012	CcSEcCtD
Bromocriptine—Muscle spasms—Docetaxel—pancreatic cancer	0.000361	0.0012	CcSEcCtD
Bromocriptine—Dizziness—Sunitinib—pancreatic cancer	0.000356	0.00118	CcSEcCtD
Bromocriptine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000356	0.00118	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000356	0.00118	CcSEcCtD
Bromocriptine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000356	0.00118	CcSEcCtD
Bromocriptine—Abdominal pain—Irinotecan—pancreatic cancer	0.000351	0.00116	CcSEcCtD
Bromocriptine—Body temperature increased—Irinotecan—pancreatic cancer	0.000351	0.00116	CcSEcCtD
Bromocriptine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00035	0.00116	CcSEcCtD
Bromocriptine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000348	0.00115	CcSEcCtD
Bromocriptine—Vomiting—Sunitinib—pancreatic cancer	0.000342	0.00113	CcSEcCtD
Bromocriptine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000342	0.00113	CcSEcCtD
Bromocriptine—Rash—Sunitinib—pancreatic cancer	0.00034	0.00112	CcSEcCtD
Bromocriptine—Dermatitis—Sunitinib—pancreatic cancer	0.000339	0.00112	CcSEcCtD
Bromocriptine—Urticaria—Fluorouracil—pancreatic cancer	0.000338	0.00112	CcSEcCtD
Bromocriptine—Headache—Sunitinib—pancreatic cancer	0.000337	0.00112	CcSEcCtD
Bromocriptine—Syncope—Docetaxel—pancreatic cancer	0.000337	0.00112	CcSEcCtD
Bromocriptine—Dysphagia—Doxorubicin—pancreatic cancer	0.000337	0.00111	CcSEcCtD
Bromocriptine—Influenza—Doxorubicin—pancreatic cancer	0.000337	0.00111	CcSEcCtD
Bromocriptine—Pollakiuria—Epirubicin—pancreatic cancer	0.000336	0.00111	CcSEcCtD
Bromocriptine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000336	0.00111	CcSEcCtD
Bromocriptine—Loss of consciousness—Docetaxel—pancreatic cancer	0.00033	0.00109	CcSEcCtD
Bromocriptine—Convulsion—Docetaxel—pancreatic cancer	0.000326	0.00108	CcSEcCtD
Bromocriptine—Hypertension—Docetaxel—pancreatic cancer	0.000324	0.00107	CcSEcCtD
Bromocriptine—Drowsiness—Epirubicin—pancreatic cancer	0.000324	0.00107	CcSEcCtD
Bromocriptine—Nausea—Sunitinib—pancreatic cancer	0.00032	0.00106	CcSEcCtD
Bromocriptine—Asthenia—Irinotecan—pancreatic cancer	0.000318	0.00105	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000318	0.00105	CcSEcCtD
Bromocriptine—Dry mouth—Docetaxel—pancreatic cancer	0.000313	0.00104	CcSEcCtD
Bromocriptine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000311	0.00103	CcSEcCtD
Bromocriptine—Asthenia—Gemcitabine—pancreatic cancer	0.00031	0.00103	CcSEcCtD
Bromocriptine—Confusional state—Docetaxel—pancreatic cancer	0.000309	0.00102	CcSEcCtD
Bromocriptine—Oedema—Docetaxel—pancreatic cancer	0.000307	0.00102	CcSEcCtD
Bromocriptine—Infection—Docetaxel—pancreatic cancer	0.000305	0.00101	CcSEcCtD
Bromocriptine—Sinusitis—Epirubicin—pancreatic cancer	0.000304	0.00101	CcSEcCtD
Bromocriptine—Diarrhoea—Irinotecan—pancreatic cancer	0.000304	0.00101	CcSEcCtD
Bromocriptine—Shock—Docetaxel—pancreatic cancer	0.000302	0.000999	CcSEcCtD
Bromocriptine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000301	0.000996	CcSEcCtD
Bromocriptine—Drowsiness—Doxorubicin—pancreatic cancer	0.0003	0.000994	CcSEcCtD
Bromocriptine—Tachycardia—Docetaxel—pancreatic cancer	0.000299	0.000991	CcSEcCtD
Bromocriptine—Skin disorder—Docetaxel—pancreatic cancer	0.000298	0.000986	CcSEcCtD
Bromocriptine—Bradycardia—Epirubicin—pancreatic cancer	0.000296	0.000981	CcSEcCtD
Bromocriptine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000296	0.000979	CcSEcCtD
Bromocriptine—Dizziness—Irinotecan—pancreatic cancer	0.000293	0.000971	CcSEcCtD
Bromocriptine—Anorexia—Docetaxel—pancreatic cancer	0.000292	0.000968	CcSEcCtD
Bromocriptine—Rhinitis—Epirubicin—pancreatic cancer	0.000292	0.000966	CcSEcCtD
Bromocriptine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000291	0.000963	CcSEcCtD
Bromocriptine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00029	0.000959	CcSEcCtD
Bromocriptine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000287	0.00095	CcSEcCtD
Bromocriptine—Hypotension—Docetaxel—pancreatic cancer	0.000287	0.000949	CcSEcCtD
Bromocriptine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000286	0.000947	CcSEcCtD
Bromocriptine—Vomiting—Irinotecan—pancreatic cancer	0.000282	0.000934	CcSEcCtD
Bromocriptine—Sinusitis—Doxorubicin—pancreatic cancer	0.000282	0.000932	CcSEcCtD
Bromocriptine—Dizziness—Fluorouracil—pancreatic cancer	0.000281	0.00093	CcSEcCtD
Bromocriptine—Visual impairment—Epirubicin—pancreatic cancer	0.000281	0.000929	CcSEcCtD
Bromocriptine—Rash—Irinotecan—pancreatic cancer	0.00028	0.000926	CcSEcCtD
Bromocriptine—Dermatitis—Irinotecan—pancreatic cancer	0.000279	0.000925	CcSEcCtD
Bromocriptine—Headache—Irinotecan—pancreatic cancer	0.000278	0.00092	CcSEcCtD
Bromocriptine—Insomnia—Docetaxel—pancreatic cancer	0.000277	0.000918	CcSEcCtD
Bromocriptine—Paraesthesia—Docetaxel—pancreatic cancer	0.000275	0.000912	CcSEcCtD
Bromocriptine—Vomiting—Gemcitabine—pancreatic cancer	0.000275	0.00091	CcSEcCtD
Bromocriptine—Bradycardia—Doxorubicin—pancreatic cancer	0.000274	0.000908	CcSEcCtD
Bromocriptine—Dyspnoea—Docetaxel—pancreatic cancer	0.000273	0.000905	CcSEcCtD
Bromocriptine—Somnolence—Docetaxel—pancreatic cancer	0.000273	0.000903	CcSEcCtD
Bromocriptine—Rash—Gemcitabine—pancreatic cancer	0.000272	0.000902	CcSEcCtD
Bromocriptine—Dermatitis—Gemcitabine—pancreatic cancer	0.000272	0.000901	CcSEcCtD
Bromocriptine—Eye disorder—Epirubicin—pancreatic cancer	0.000272	0.000901	CcSEcCtD
Bromocriptine—Tinnitus—Epirubicin—pancreatic cancer	0.000271	0.000899	CcSEcCtD
Bromocriptine—Headache—Gemcitabine—pancreatic cancer	0.000271	0.000896	CcSEcCtD
Bromocriptine—Cardiac disorder—Epirubicin—pancreatic cancer	0.00027	0.000895	CcSEcCtD
Bromocriptine—Vomiting—Fluorouracil—pancreatic cancer	0.00027	0.000895	CcSEcCtD
Bromocriptine—Rhinitis—Doxorubicin—pancreatic cancer	0.00027	0.000894	CcSEcCtD
Bromocriptine—Dyspepsia—Docetaxel—pancreatic cancer	0.00027	0.000894	CcSEcCtD
Bromocriptine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000268	0.000888	CcSEcCtD
Bromocriptine—Rash—Fluorouracil—pancreatic cancer	0.000268	0.000887	CcSEcCtD
Bromocriptine—Dermatitis—Fluorouracil—pancreatic cancer	0.000268	0.000886	CcSEcCtD
Bromocriptine—Decreased appetite—Docetaxel—pancreatic cancer	0.000267	0.000883	CcSEcCtD
Bromocriptine—Headache—Fluorouracil—pancreatic cancer	0.000266	0.000881	CcSEcCtD
Bromocriptine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000265	0.000879	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000265	0.000877	CcSEcCtD
Bromocriptine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000265	0.000877	CcSEcCtD
Bromocriptine—Fatigue—Docetaxel—pancreatic cancer	0.000264	0.000875	CcSEcCtD
Bromocriptine—Angiopathy—Epirubicin—pancreatic cancer	0.000264	0.000875	CcSEcCtD
Bromocriptine—Nausea—Irinotecan—pancreatic cancer	0.000264	0.000873	CcSEcCtD
Bromocriptine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000262	0.000869	CcSEcCtD
Bromocriptine—Constipation—Docetaxel—pancreatic cancer	0.000262	0.000868	CcSEcCtD
Bromocriptine—Arrhythmia—Epirubicin—pancreatic cancer	0.00026	0.000861	CcSEcCtD
Bromocriptine—Visual impairment—Doxorubicin—pancreatic cancer	0.00026	0.00086	CcSEcCtD
Bromocriptine—Alopecia—Epirubicin—pancreatic cancer	0.000257	0.000852	CcSEcCtD
Bromocriptine—Nausea—Gemcitabine—pancreatic cancer	0.000257	0.00085	CcSEcCtD
Bromocriptine—Mental disorder—Epirubicin—pancreatic cancer	0.000255	0.000845	CcSEcCtD
Bromocriptine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000253	0.000837	CcSEcCtD
Bromocriptine—Nausea—Fluorouracil—pancreatic cancer	0.000252	0.000836	CcSEcCtD
Bromocriptine—Eye disorder—Doxorubicin—pancreatic cancer	0.000252	0.000834	CcSEcCtD
Bromocriptine—Tinnitus—Doxorubicin—pancreatic cancer	0.000251	0.000832	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000251	0.00083	CcSEcCtD
Bromocriptine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00025	0.000828	CcSEcCtD
Bromocriptine—Tension—Epirubicin—pancreatic cancer	0.000249	0.000824	CcSEcCtD
Bromocriptine—Dysgeusia—Epirubicin—pancreatic cancer	0.000248	0.000822	CcSEcCtD
Bromocriptine—Nervousness—Epirubicin—pancreatic cancer	0.000246	0.000815	CcSEcCtD
Bromocriptine—Angiopathy—Doxorubicin—pancreatic cancer	0.000244	0.000809	CcSEcCtD
Bromocriptine—Muscle spasms—Epirubicin—pancreatic cancer	0.000244	0.000807	CcSEcCtD
Bromocriptine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000243	0.000804	CcSEcCtD
Bromocriptine—Abdominal pain—Docetaxel—pancreatic cancer	0.000242	0.000803	CcSEcCtD
Bromocriptine—Body temperature increased—Docetaxel—pancreatic cancer	0.000242	0.000803	CcSEcCtD
Bromocriptine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000241	0.000797	CcSEcCtD
Bromocriptine—Vision blurred—Epirubicin—pancreatic cancer	0.000239	0.000791	CcSEcCtD
Bromocriptine—Alopecia—Doxorubicin—pancreatic cancer	0.000238	0.000788	CcSEcCtD
Bromocriptine—Mental disorder—Doxorubicin—pancreatic cancer	0.000236	0.000781	CcSEcCtD
Bromocriptine—Agitation—Epirubicin—pancreatic cancer	0.000233	0.000771	CcSEcCtD
Bromocriptine—Tension—Doxorubicin—pancreatic cancer	0.00023	0.000762	CcSEcCtD
Bromocriptine—Dysgeusia—Doxorubicin—pancreatic cancer	0.00023	0.00076	CcSEcCtD
Bromocriptine—Nervousness—Doxorubicin—pancreatic cancer	0.000228	0.000754	CcSEcCtD
Bromocriptine—Vertigo—Epirubicin—pancreatic cancer	0.000228	0.000754	CcSEcCtD
Bromocriptine—Syncope—Epirubicin—pancreatic cancer	0.000227	0.000753	CcSEcCtD
Bromocriptine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000225	0.000747	CcSEcCtD
Bromocriptine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000223	0.000738	CcSEcCtD
Bromocriptine—Vision blurred—Doxorubicin—pancreatic cancer	0.000221	0.000732	CcSEcCtD
Bromocriptine—Asthenia—Docetaxel—pancreatic cancer	0.00022	0.000729	CcSEcCtD
Bromocriptine—Convulsion—Epirubicin—pancreatic cancer	0.00022	0.000727	CcSEcCtD
Bromocriptine—Hypertension—Epirubicin—pancreatic cancer	0.000219	0.000725	CcSEcCtD
Bromocriptine—Agitation—Doxorubicin—pancreatic cancer	0.000216	0.000714	CcSEcCtD
Bromocriptine—Anxiety—Epirubicin—pancreatic cancer	0.000215	0.000712	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000214	0.00071	CcSEcCtD
Bromocriptine—Dry mouth—Epirubicin—pancreatic cancer	0.000211	0.000699	CcSEcCtD
Bromocriptine—Vertigo—Doxorubicin—pancreatic cancer	0.000211	0.000698	CcSEcCtD
Bromocriptine—Syncope—Doxorubicin—pancreatic cancer	0.00021	0.000696	CcSEcCtD
Bromocriptine—Diarrhoea—Docetaxel—pancreatic cancer	0.00021	0.000695	CcSEcCtD
Bromocriptine—Confusional state—Epirubicin—pancreatic cancer	0.000209	0.000691	CcSEcCtD
Bromocriptine—Oedema—Epirubicin—pancreatic cancer	0.000207	0.000685	CcSEcCtD
Bromocriptine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000206	0.000682	CcSEcCtD
Bromocriptine—Infection—Epirubicin—pancreatic cancer	0.000206	0.00068	CcSEcCtD
Bromocriptine—Shock—Epirubicin—pancreatic cancer	0.000204	0.000674	CcSEcCtD
Bromocriptine—Convulsion—Doxorubicin—pancreatic cancer	0.000203	0.000673	CcSEcCtD
Bromocriptine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000203	0.000672	CcSEcCtD
Bromocriptine—Dizziness—Docetaxel—pancreatic cancer	0.000203	0.000671	CcSEcCtD
Bromocriptine—Hypertension—Doxorubicin—pancreatic cancer	0.000202	0.00067	CcSEcCtD
Bromocriptine—Tachycardia—Epirubicin—pancreatic cancer	0.000202	0.000668	CcSEcCtD
Bromocriptine—Skin disorder—Epirubicin—pancreatic cancer	0.000201	0.000665	CcSEcCtD
Bromocriptine—Anxiety—Doxorubicin—pancreatic cancer	0.000199	0.000659	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000198	0.000657	CcSEcCtD
Bromocriptine—Anorexia—Epirubicin—pancreatic cancer	0.000197	0.000653	CcSEcCtD
Bromocriptine—Dry mouth—Doxorubicin—pancreatic cancer	0.000195	0.000647	CcSEcCtD
Bromocriptine—Vomiting—Docetaxel—pancreatic cancer	0.000195	0.000646	CcSEcCtD
Bromocriptine—Rash—Docetaxel—pancreatic cancer	0.000193	0.00064	CcSEcCtD
Bromocriptine—Hypotension—Epirubicin—pancreatic cancer	0.000193	0.00064	CcSEcCtD
Bromocriptine—Dermatitis—Docetaxel—pancreatic cancer	0.000193	0.00064	CcSEcCtD
Bromocriptine—Confusional state—Doxorubicin—pancreatic cancer	0.000193	0.000639	CcSEcCtD
Bromocriptine—Headache—Docetaxel—pancreatic cancer	0.000192	0.000636	CcSEcCtD
Bromocriptine—Oedema—Doxorubicin—pancreatic cancer	0.000191	0.000634	CcSEcCtD
Bromocriptine—Infection—Doxorubicin—pancreatic cancer	0.00019	0.00063	CcSEcCtD
Bromocriptine—Shock—Doxorubicin—pancreatic cancer	0.000188	0.000623	CcSEcCtD
Bromocriptine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000188	0.000621	CcSEcCtD
Bromocriptine—Insomnia—Epirubicin—pancreatic cancer	0.000187	0.000619	CcSEcCtD
Bromocriptine—Tachycardia—Doxorubicin—pancreatic cancer	0.000187	0.000619	CcSEcCtD
Bromocriptine—Skin disorder—Doxorubicin—pancreatic cancer	0.000186	0.000616	CcSEcCtD
Bromocriptine—Paraesthesia—Epirubicin—pancreatic cancer	0.000186	0.000615	CcSEcCtD
Bromocriptine—Dyspnoea—Epirubicin—pancreatic cancer	0.000184	0.000611	CcSEcCtD
Bromocriptine—Somnolence—Epirubicin—pancreatic cancer	0.000184	0.000609	CcSEcCtD
Bromocriptine—Anorexia—Doxorubicin—pancreatic cancer	0.000182	0.000604	CcSEcCtD
Bromocriptine—Nausea—Docetaxel—pancreatic cancer	0.000182	0.000603	CcSEcCtD
Bromocriptine—Dyspepsia—Epirubicin—pancreatic cancer	0.000182	0.000603	CcSEcCtD
Bromocriptine—Decreased appetite—Epirubicin—pancreatic cancer	0.00018	0.000595	CcSEcCtD
Bromocriptine—Hypotension—Doxorubicin—pancreatic cancer	0.000179	0.000592	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000179	0.000591	CcSEcCtD
Bromocriptine—Fatigue—Epirubicin—pancreatic cancer	0.000178	0.00059	CcSEcCtD
Bromocriptine—Constipation—Epirubicin—pancreatic cancer	0.000177	0.000586	CcSEcCtD
Bromocriptine—Insomnia—Doxorubicin—pancreatic cancer	0.000173	0.000573	CcSEcCtD
Bromocriptine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000172	0.000569	CcSEcCtD
Bromocriptine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000171	0.000565	CcSEcCtD
Bromocriptine—Feeling abnormal—Epirubicin—pancreatic cancer	0.00017	0.000564	CcSEcCtD
Bromocriptine—Somnolence—Doxorubicin—pancreatic cancer	0.00017	0.000563	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000169	0.00056	CcSEcCtD
Bromocriptine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000168	0.000558	CcSEcCtD
Bromocriptine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000166	0.000551	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000165	0.000547	CcSEcCtD
Bromocriptine—Fatigue—Doxorubicin—pancreatic cancer	0.000165	0.000546	CcSEcCtD
Bromocriptine—Urticaria—Epirubicin—pancreatic cancer	0.000164	0.000544	CcSEcCtD
Bromocriptine—Constipation—Doxorubicin—pancreatic cancer	0.000164	0.000542	CcSEcCtD
Bromocriptine—Abdominal pain—Epirubicin—pancreatic cancer	0.000164	0.000541	CcSEcCtD
Bromocriptine—Body temperature increased—Epirubicin—pancreatic cancer	0.000164	0.000541	CcSEcCtD
Bromocriptine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000158	0.000522	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000157	0.000518	CcSEcCtD
Bromocriptine—Urticaria—Doxorubicin—pancreatic cancer	0.000152	0.000503	CcSEcCtD
Bromocriptine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000151	0.000501	CcSEcCtD
Bromocriptine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000151	0.000501	CcSEcCtD
Bromocriptine—Asthenia—Epirubicin—pancreatic cancer	0.000148	0.000491	CcSEcCtD
Bromocriptine—Diarrhoea—Epirubicin—pancreatic cancer	0.000142	0.000469	CcSEcCtD
Bromocriptine—Asthenia—Doxorubicin—pancreatic cancer	0.000137	0.000455	CcSEcCtD
Bromocriptine—Dizziness—Epirubicin—pancreatic cancer	0.000137	0.000453	CcSEcCtD
Bromocriptine—Vomiting—Epirubicin—pancreatic cancer	0.000132	0.000435	CcSEcCtD
Bromocriptine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000131	0.000434	CcSEcCtD
Bromocriptine—Rash—Epirubicin—pancreatic cancer	0.00013	0.000432	CcSEcCtD
Bromocriptine—Dermatitis—Epirubicin—pancreatic cancer	0.00013	0.000431	CcSEcCtD
Bromocriptine—Headache—Epirubicin—pancreatic cancer	0.00013	0.000429	CcSEcCtD
Bromocriptine—Dizziness—Doxorubicin—pancreatic cancer	0.000127	0.000419	CcSEcCtD
Bromocriptine—Nausea—Epirubicin—pancreatic cancer	0.000123	0.000407	CcSEcCtD
Bromocriptine—Vomiting—Doxorubicin—pancreatic cancer	0.000122	0.000403	CcSEcCtD
Bromocriptine—Rash—Doxorubicin—pancreatic cancer	0.000121	0.0004	CcSEcCtD
Bromocriptine—Dermatitis—Doxorubicin—pancreatic cancer	0.000121	0.000399	CcSEcCtD
Bromocriptine—Headache—Doxorubicin—pancreatic cancer	0.00012	0.000397	CcSEcCtD
Bromocriptine—Nausea—Doxorubicin—pancreatic cancer	0.000114	0.000376	CcSEcCtD
Bromocriptine—ADRA2A—islet of Langerhans—pancreatic cancer	0.000103	0.0329	CbGeAlD
Bromocriptine—HTR2B—digestive system—pancreatic cancer	9.89e-05	0.0314	CbGeAlD
Bromocriptine—ADRA2C—pancreas—pancreatic cancer	9.12e-05	0.0289	CbGeAlD
Bromocriptine—HTR7—digestive system—pancreatic cancer	8.47e-05	0.0269	CbGeAlD
Bromocriptine—ADRA2A—pancreas—pancreatic cancer	7.28e-05	0.0231	CbGeAlD
Bromocriptine—CYP1A2—digestive system—pancreatic cancer	6.76e-05	0.0215	CbGeAlD
Bromocriptine—ABCB1—islet of Langerhans—pancreatic cancer	5.77e-05	0.0183	CbGeAlD
Bromocriptine—HTR2A—digestive system—pancreatic cancer	5.28e-05	0.0168	CbGeAlD
Bromocriptine—CYP3A4—digestive system—pancreatic cancer	4.89e-05	0.0155	CbGeAlD
Bromocriptine—ABCB1—pancreas—pancreatic cancer	4.05e-05	0.0129	CbGeAlD
Bromocriptine—ABCB1—digestive system—pancreatic cancer	3.46e-05	0.011	CbGeAlD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	8.3e-06	2.82e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	8.28e-06	2.82e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	8.28e-06	2.82e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	8.27e-06	2.82e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MMP9—pancreatic cancer	8.25e-06	2.81e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	8.23e-06	2.8e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	8.22e-06	2.8e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—SRC—pancreatic cancer	8.22e-06	2.8e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PTEN—pancreatic cancer	8.2e-06	2.79e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MYC—pancreatic cancer	8.19e-06	2.79e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TGFB1—pancreatic cancer	8.17e-06	2.78e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	8.15e-06	2.77e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	8.14e-06	2.77e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	8.12e-06	2.76e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—STK11—pancreatic cancer	8.12e-06	2.76e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	8.09e-06	2.75e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MYC—pancreatic cancer	8.08e-06	2.75e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MYC—pancreatic cancer	8.08e-06	2.75e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—PIK3CA—pancreatic cancer	8.08e-06	2.75e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	8.07e-06	2.75e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—PIK3CA—pancreatic cancer	8.07e-06	2.75e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TGFB1—pancreatic cancer	8.06e-06	2.74e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TGFB1—pancreatic cancer	8.06e-06	2.74e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PPARG—pancreatic cancer	8.03e-06	2.73e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—KRAS—pancreatic cancer	8.03e-06	2.73e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—PIK3CA—pancreatic cancer	8.02e-06	2.73e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—EGFR—pancreatic cancer	8.01e-06	2.73e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	8.01e-06	2.72e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—AKT1—pancreatic cancer	8e-06	2.72e-05	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	8e-06	2.72e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	7.98e-06	2.71e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PTEN—pancreatic cancer	7.97e-06	2.71e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	7.96e-06	2.71e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	7.93e-06	2.7e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	7.93e-06	2.7e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	7.92e-06	2.7e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	7.92e-06	2.7e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	7.91e-06	2.69e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EGFR—pancreatic cancer	7.91e-06	2.69e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EGFR—pancreatic cancer	7.91e-06	2.69e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	7.88e-06	2.68e-05	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	7.87e-06	2.68e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SRC—pancreatic cancer	7.86e-06	2.68e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	7.85e-06	2.67e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—PIK3CA—pancreatic cancer	7.85e-06	2.67e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	7.84e-06	2.67e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SRC—pancreatic cancer	7.82e-06	2.66e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—pancreatic cancer	7.82e-06	2.66e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—pancreatic cancer	7.81e-06	2.66e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	7.8e-06	2.65e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—pancreatic cancer	7.76e-06	2.64e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—PIK3CA—pancreatic cancer	7.73e-06	2.63e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	7.71e-06	2.62e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	7.71e-06	2.62e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	7.7e-06	2.62e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	7.66e-06	2.61e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	7.64e-06	2.6e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	7.63e-06	2.6e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	7.62e-06	2.59e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SRC—pancreatic cancer	7.61e-06	2.59e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—pancreatic cancer	7.6e-06	2.59e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	7.59e-06	2.58e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	7.58e-06	2.58e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—KRAS—pancreatic cancer	7.57e-06	2.58e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	7.56e-06	2.57e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	7.54e-06	2.57e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	7.52e-06	2.56e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	7.51e-06	2.56e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	7.49e-06	2.55e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	7.49e-06	2.55e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—HRAS—pancreatic cancer	7.48e-06	2.54e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—pancreatic cancer	7.47e-06	2.54e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	7.47e-06	2.54e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—KRAS—pancreatic cancer	7.47e-06	2.54e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—HRAS—pancreatic cancer	7.47e-06	2.54e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	7.44e-06	2.53e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	7.43e-06	2.53e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—HRAS—pancreatic cancer	7.42e-06	2.52e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	7.41e-06	2.52e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	7.41e-06	2.52e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—PIK3CA—pancreatic cancer	7.38e-06	2.51e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	7.37e-06	2.51e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MYC—pancreatic cancer	7.37e-06	2.51e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	7.36e-06	2.51e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOE—pancreatic cancer	7.36e-06	2.51e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	7.36e-06	2.5e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	7.35e-06	2.5e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	7.34e-06	2.5e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	7.32e-06	2.49e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	7.32e-06	2.49e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	7.32e-06	2.49e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	7.3e-06	2.48e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	7.29e-06	2.48e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	7.28e-06	2.48e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	7.26e-06	2.47e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	7.26e-06	2.47e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	7.22e-06	2.46e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	7.21e-06	2.46e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	7.2e-06	2.45e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	7.2e-06	2.45e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	7.17e-06	2.44e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	7.16e-06	2.44e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—HRAS—pancreatic cancer	7.15e-06	2.43e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	7.15e-06	2.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	7.14e-06	2.43e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—pancreatic cancer	7.13e-06	2.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	7.09e-06	2.41e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	7.05e-06	2.4e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	7.03e-06	2.39e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	7.01e-06	2.39e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	7e-06	2.38e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	6.99e-06	2.38e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—TYMS—pancreatic cancer	6.99e-06	2.38e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.97e-06	2.37e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—PIK3CA—pancreatic cancer	6.96e-06	2.37e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	6.92e-06	2.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	6.9e-06	2.35e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SRC—pancreatic cancer	6.9e-06	2.35e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	6.89e-06	2.35e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	6.86e-06	2.34e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	6.86e-06	2.34e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	6.86e-06	2.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	6.84e-06	2.33e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—HRAS—pancreatic cancer	6.82e-06	2.32e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	6.82e-06	2.32e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	6.81e-06	2.32e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	6.8e-06	2.31e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	6.79e-06	2.31e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	6.74e-06	2.3e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—pancreatic cancer	6.73e-06	2.29e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	6.72e-06	2.29e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	6.71e-06	2.28e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	6.7e-06	2.28e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	6.69e-06	2.28e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	6.67e-06	2.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	6.66e-06	2.27e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	6.66e-06	2.27e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	6.65e-06	2.26e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	6.64e-06	2.26e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	6.64e-06	2.26e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	6.64e-06	2.26e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—pancreatic cancer	6.64e-06	2.26e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	6.62e-06	2.25e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AKT1—pancreatic cancer	6.6e-06	2.25e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AKT1—pancreatic cancer	6.59e-06	2.24e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	6.56e-06	2.23e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AKT1—pancreatic cancer	6.55e-06	2.23e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	6.55e-06	2.23e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	6.53e-06	2.22e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	6.51e-06	2.22e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	6.5e-06	2.21e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	6.48e-06	2.2e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	6.48e-06	2.2e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—HRAS—pancreatic cancer	6.43e-06	2.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	6.41e-06	2.18e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	6.41e-06	2.18e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPARG—pancreatic cancer	6.41e-06	2.18e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	6.4e-06	2.18e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	6.38e-06	2.17e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	6.35e-06	2.16e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—HRAS—pancreatic cancer	6.35e-06	2.16e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—pancreatic cancer	6.32e-06	2.15e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AKT1—pancreatic cancer	6.31e-06	2.15e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	6.3e-06	2.14e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	6.25e-06	2.13e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	6.2e-06	2.11e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	6.2e-06	2.11e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MYC—pancreatic cancer	6.19e-06	2.11e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	6.18e-06	2.1e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	6.17e-06	2.1e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	6.09e-06	2.07e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	6.07e-06	2.07e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	6.05e-06	2.06e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—pancreatic cancer	6.05e-06	2.06e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AKT1—pancreatic cancer	6.03e-06	2.05e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	6.02e-06	2.05e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	5.99e-06	2.04e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	5.98e-06	2.04e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	5.96e-06	2.03e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	5.96e-06	2.03e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	5.95e-06	2.03e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	5.95e-06	2.03e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	5.95e-06	2.02e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	5.94e-06	2.02e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	5.84e-06	1.99e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	5.83e-06	1.98e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	5.79e-06	1.97e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	5.79e-06	1.97e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	5.79e-06	1.97e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	5.76e-06	1.96e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	5.73e-06	1.95e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	5.72e-06	1.95e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	5.7e-06	1.94e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AKT1—pancreatic cancer	5.68e-06	1.93e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOE—pancreatic cancer	5.68e-06	1.93e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AKT1—pancreatic cancer	5.65e-06	1.92e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	5.62e-06	1.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	5.62e-06	1.91e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	5.61e-06	1.91e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AKT1—pancreatic cancer	5.61e-06	1.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	5.6e-06	1.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	5.54e-06	1.88e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	5.53e-06	1.88e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	5.52e-06	1.88e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTEN—pancreatic cancer	5.51e-06	1.88e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	5.51e-06	1.88e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	5.51e-06	1.87e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	5.51e-06	1.87e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	5.42e-06	1.84e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	5.35e-06	1.82e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	5.27e-06	1.79e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	5.25e-06	1.79e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	5.17e-06	1.76e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.13e-06	1.75e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	5.12e-06	1.74e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	5.11e-06	1.74e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	5.09e-06	1.73e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—pancreatic cancer	5.08e-06	1.73e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	5.06e-06	1.72e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	5.06e-06	1.72e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	5.04e-06	1.72e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	5e-06	1.7e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.95e-06	1.68e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	4.89e-06	1.67e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	4.89e-06	1.66e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	4.86e-06	1.65e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	4.86e-06	1.65e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	4.78e-06	1.63e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	4.73e-06	1.61e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	4.7e-06	1.6e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	4.68e-06	1.59e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	4.65e-06	1.58e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AKT1—pancreatic cancer	4.59e-06	1.56e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	4.55e-06	1.55e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.51e-06	1.53e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTEN—pancreatic cancer	4.4e-06	1.5e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	4.35e-06	1.48e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	4.29e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	4.22e-06	1.44e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	4.13e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.93e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.89e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.89e-06	1.32e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	3.84e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.4e-06	1.16e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AKT1—pancreatic cancer	3.18e-06	1.08e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	3.1e-06	1.06e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AKT1—pancreatic cancer	2.54e-06	8.63e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.4e-06	8.15e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.96e-06	6.66e-06	CbGpPWpGaD
